BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Bio NC

  Chelsea Therapeutics, Inc. to Present At the UBS Warburg Global Life Sciences Conference On Monday, September 22, 2008

  September 16, 2008

   · 

  1 min read
• Drug Development

  Generex Biotechnology Corporation Announces Enrollment of More Than Two Hundred Subjects in Generex Oral-lyn Phase III Trial

  September 16, 2008

   · 

  1 min read
• Business

  Pharmacopeia, Inc. and GlaxoSmithKline Collaboration Identifies Sixth Lead Compound

  September 16, 2008

   · 

  1 min read
• Drug Development

  Oramed Pharmaceuticals Inc. Launches GLP1-Analog Program

  September 16, 2008

   · 

  2 min read
• Deals

  Evotec AG Participates in the Sale of Direvo Biotech AG to Bayer HealthCare

  September 16, 2008

   · 

  1 min read
• Business

  New Programs Added in Antibody Collaboration Between XOMA (US) LLC and Takeda Pharmaceutical Co. Ltd.

  September 16, 2008

   · 

  1 min read
• Drug Development

  Cadence Pharmaceuticals, Inc. Updates Omigard(TM) Clinical Timeline

  September 16, 2008

   · 

  4 min read
• Biotech Bay

  WorldHeart Receives Favorable Decision to Continue NASDAQ Listing

  September 16, 2008

   · 

  3 min read
• Drug Development

  InNexus Inc. Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies

  September 16, 2008

   · 

  3 min read
• Business

  AMDL, Inc. Reaffirms 2008 Guidance and Provides Additional Information

  September 16, 2008

   · 

  4 min read